In a significant move that promises to reshape India's renal care landscape, diversified healthcare group Lord's Mark Industries Ltd. has announced the strategic acquisition of an 85 percent stake in Bengaluru-based med-tech innovator Renalyx Health Systems Private Limited.
Boosting Indigenous Medical Technology
The acquisition represents a major step forward in India's medical technology sector, particularly for patients suffering from chronic kidney disease. Renalyx Health Systems is the creator of India's first fully indigenous, AI and cloud-enabled smart hemodialysis machine, positioning the company at the forefront of medical innovation.
Under the new ownership structure, Renalyx will function as the dedicated research and development hub for Lord's Mark Industries, focusing specifically on developing next-generation medical devices for kidney and liver care. This strategic alignment aims to accelerate innovation in critical healthcare areas where India faces growing challenges.
Transforming Renal Care Through Technology
The flagship hemodialysis machine developed by Renalyx incorporates several groundbreaking features that set it apart from conventional dialysis equipment. The technology integrates:
- Real-time remote monitoring capabilities
- Cloud-based clinical connectivity systems
- Advanced intelligent analytics
These technological advancements enable hospitals, dialysis centers, and clinicians to deliver safer, more reliable, and significantly more cost-efficient renal therapy to patients across India.
Sachidanand Upadhyay, Managing Director of Lord's Mark Industries Ltd., emphasized the transformative potential of this acquisition. "Our investment in Renalyx is a forward-looking bet on the future of Indian healthcare, one where cutting-edge med-tech is designed, engineered, and manufactured in India for India and the world," he stated.
Expanding Access to Quality Healthcare
The acquisition marks a decisive step in Lord's Mark Industries' expansion into next-generation medical technologies that address India's growing burden of chronic kidney disease. With renal care becoming increasingly critical in Indian healthcare, this move positions the company to make a substantial impact.
"Dialysis must move from being a high-cost, infrastructure-heavy service to a smart, connected, and patient-centric experience," Upadhyay added. "By bringing Renalyx into our fold, we are accelerating that shift. We see this as a transformative opportunity to democratize advanced renal care, strengthen Make in India innovation, and build medical technologies that redefine accessibility and clinical excellence at scale."
With Renalyx now integrated into its healthcare ecosystem, Lord's Mark Industries Ltd. is well-positioned to scale its indigenous dialysis infrastructure, enhance clinical outcomes, and expand access to quality renal care across Tier 1 to Tier 3 markets throughout India.
Renalyx will continue to operate with its existing engineering and product teams, while leveraging Lord's Mark Industries' extensive national healthcare distribution network, diagnostics infrastructure, and manufacturing capabilities to drive faster market penetration and technology adoption.
Founded in 1998, Lord's Mark Industries Ltd. has grown into a prominent player in the healthcare and diagnostics space. The company has steadily broadened its footprint in medical diagnostics, creating a strong presence across the healthcare value chain, and this latest acquisition further strengthens its position in the evolving Indian healthcare market.
